Despite its presence on non-tumor cells, CD44 is commonly explored as a cancer-related biomarker since it is overexpressed on the cell surfaces of major cancers, such as pancreatic [60], breast [61], prostate [52], lung [62], and gastric cancer [63]. Here, CD44 is linked to cancer.